Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
top of page
- Nov 25, 2016
- 1 min
Acesion Pharma has won the prize as EY Entrepreneur of the Year 2016 in lifescience
Acesion Pharma has won the prize as EY Entrepreneur of the Year 2016 among the nominated Danish Lifesciences companies. The award was...
6 views
- Nov 15, 2016
- 1 min
Acesion Pharma recruits an experienced life science Chief Financial Officer
Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), today announced that it has recruited...
8 views
LATEST NEWS
bottom of page